Tyrosine Phosphorylation of the Nuclear Receptor Coactivator AIB1/SRC-3 Is Enhanced by Abl Kinase and Is Required for Its Activity in Cancer Cells
暂无分享,去创建一个
Sivanesan Dakshanamurthy | Anton Wellstein | John T. Lahusen | S. Dakshanamurthy | A. Wellstein | Jianming Xu | A. Riegel | Christopher D. Chien | A. Oh | M. Fereshteh | Jianming Xu | Annabell S. Oh | Mark P. Fereshteh | Xiaolong Zhang | Benjamin L. Kagan | Anna T. Riegel | Xiaolong Zhang
[1] A. Boureux,et al. The tyrosine kinase Abl is required for Src-transforming activity in mouse fibroblasts and human breast cancer cells , 2007, Oncogene.
[2] B. O’Malley,et al. Signaling within a Coactivator Complex: Methylation of SRC-3/AIB1 Is a MolecularSwitch for Complex Disassembly , 2006, Molecular and Cellular Biology.
[3] J. Torchia,et al. Microtubule-Dependent Subcellular Redistribution of the Transcriptional Coactivator p/CIP , 2002, Molecular and Cellular Biology.
[4] A. Pendergast. The Abl family kinases: mechanisms of regulation and signaling. , 2002, Advances in cancer research.
[5] Jing Liang,et al. Coordinated Regulation of AIB1 Transcriptional Activity by Sumoylation and Phosphorylation* , 2006, Journal of Biological Chemistry.
[6] N. Koibuchi,et al. TRAM-1, A Novel 160-kDa Thyroid Hormone Receptor Activator Molecule, Exhibits Distinct Properties from Steroid Receptor Coactivator-1* , 1997, The Journal of Biological Chemistry.
[7] E. Gehan,et al. The Nuclear Receptor Coactivator AIB1 Mediates Insulin-like Growth Factor I-induced Phenotypic Changes in Human Breast Cancer Cells , 2004, Cancer Research.
[8] I. Raška,et al. P38MAPK‐dependent phosphorylation and degradation of SRC‐3/AIB1 and RARα‐mediated transcription , 2006, The EMBO journal.
[9] D. Srinivasan,et al. Aggressive breast cancer cells are dependent on activated Abl kinases for proliferation, anchorage-independent growth and survival , 2008, Oncogene.
[10] M. Sternberg,et al. Enhanced genome annotation using structural profiles in the program 3D-PSSM. , 2000, Journal of molecular biology.
[11] G. Superti-Furga,et al. Structural Basis for the Autoinhibition of c-Abl Tyrosine Kinase , 2003, Cell.
[12] A. Wellstein,et al. An Isoform of the Coactivator AIB1 That Increases Hormone and Growth Factor Sensitivity Is Overexpressed in Breast Cancer* , 2001, The Journal of Biological Chemistry.
[13] B. O’Malley,et al. SRC-3 Coactivator Functional Lifetime Is Regulated by a Phospho-Dependent Ubiquitin Time Clock , 2007, Cell.
[14] P. Seeburg,et al. Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. , 2000, Science.
[15] A. Wellstein,et al. Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1. , 2007, Cancer research.
[16] Baljit Singh,et al. Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue , 2001, Breast Cancer Research and Treatment.
[17] Giulio Superti‐Furga,et al. c‐Abl is an effector of Src for growth factor‐induced c‐myc expression and DNA synthesis , 2002, The EMBO journal.
[18] P. Meltzer,et al. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. , 1997, Science.
[19] Jijie Gu,et al. p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage , 1999, Nature.
[20] Y. Zeng,et al. Correlation of AIB1 overexpression with advanced clinical stage of human colorectal carcinoma. , 2005, Human pathology.
[21] Anton Wellstein,et al. E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells. , 2006, Cancer research.
[22] M. Ittmann,et al. Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway. , 2006, Cancer research.
[23] A. Kazlauskas,et al. c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. , 1999, Genes & development.
[24] B. O’Malley,et al. Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis. , 2005, Cancer research.
[25] M. Louie,et al. ACTR/AIB1 Functions as an E2F1 Coactivator To Promote Breast Cancer Cell Proliferation and Antiestrogen Resistance , 2004, Molecular and Cellular Biology.
[26] B. O’Malley,et al. Specific Amino Acid Residues in the Basic Helix-Loop-Helix Domain of SRC-3 Are Essential for Its Nuclear Localization and Proteasome-Dependent Turnover , 2006, Molecular and Cellular Biology.
[27] G. Superti-Furga,et al. A nuclear tyrosine phosphorylation circuit: c‐Jun as an activator and substrate of c‐Abl and JNK , 2000, The EMBO journal.
[28] M. Tilli,et al. Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice. , 2005, Molecular endocrinology.
[29] R. V. van Etten,et al. Cycling, stressed-out and nervous: cellular functions of c-Abl. , 1999, Trends in cell biology.
[30] C. Powers,et al. Ribozyme Targeting Demonstrates That the Nuclear Receptor Coactivator AIB1 Is a Rate-limiting Factor for Estrogen-dependent Growth of Human MCF-7 Breast Cancer Cells* , 2001, The Journal of Biological Chemistry.
[31] R. Evans,et al. Nuclear Receptor Coactivator ACTR Is a Novel Histone Acetyltransferase and Forms a Multimeric Activation Complex with P/CAF and CBP/p300 , 1997, Cell.
[32] A. Mandarino,et al. Role of c-Abl in Directing Metabolic versus Mitogenic Effects in Insulin Receptor Signaling* , 2007, Journal of Biological Chemistry.
[33] E. Myers,et al. Basic local alignment search tool. , 1990, Journal of molecular biology.
[34] W. Sellers,et al. High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene. , 2004, Cancer cell.
[35] Oliver Hantschel,et al. Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase. , 2006, Molecular cell.
[36] Yusuke Nakamura,et al. Amplification and over‐expression of the AIB1 nuclear receptor co‐activator gene in primary gastric cancers , 2000, International journal of cancer.
[37] N. Heisterkamp,et al. Tyrosine 207 in CRKL is the BCR/ABL phosphorylation site , 1997, Oncogene.
[38] O. Hermanson,et al. Regulation of somatic growth by the p160 coactivator p/CIP. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[39] Hui Li,et al. RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[40] M. Southey,et al. Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu. , 2001, Cancer research.
[41] A. Wellstein,et al. Induction of the Angiogenic Modulator Fibroblast Growth Factor-binding Protein by Epidermal Growth Factor Is Mediated through Both MEK/ERK and p38 Signal Transduction Pathways* , 2000, The Journal of Biological Chemistry.
[42] James D. Griffin,et al. p130CAS Forms a Signaling Complex with the Adapter Protein CRKL in Hematopoietic Cells Transformed by the BCR/ABL Oncogene* , 1996, The Journal of Biological Chemistry.
[43] A. Maitra,et al. Overexpression of the Nuclear Receptor Coactivator AIB1 (SRC-3) during Progression of Pancreatic Adenocarcinoma , 2004, Clinical Cancer Research.
[44] G. Superti-Furga,et al. A Myristoyl/Phosphotyrosine Switch Regulates c-Abl , 2003, Cell.
[45] Adrian V. Lee,et al. AIB1/SRC-3 Deficiency Affects Insulin-Like Growth Factor I Signaling Pathway and Suppresses v-Ha-ras-induced Breast Cancer Initiation and Progression in Mice , 2004, Cancer Research.
[46] S. Feller,et al. c‐Abl kinase regulates the protein binding activity of c‐Crk. , 1994, The EMBO journal.
[47] J. Auwerx,et al. Absence of the steroid receptor coactivator‐3 induces B‐cell lymphoma , 2006, The EMBO journal.
[48] Adam T. Szafran,et al. Regulation of SRC-3 Intercompartmental Dynamics by Estrogen Receptor and Phosphorylation , 2007, Molecular and Cellular Biology.
[49] T. Hunter,et al. Critical roles of the p160 transcriptional coactivators p/CIP and SRC-1 in energy balance. , 2006, Cell metabolism.
[50] D. Baltimore,et al. Identification of the Abl- and rasGAP-Associated 62 kDa Protein as a Docking Protein, Dok , 1997, Cell.
[51] S. Hilsenbeck,et al. Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. , 2003, Journal of the National Cancer Institute.
[52] M. Tsai,et al. Role of the Steroid Receptor Coactivator SRC-3 in Cell Growth , 2003, Molecular and Cellular Biology.
[53] C. Cordon-Cardo,et al. Autocrine PDGFR signaling promotes mammary cancer metastasis. , 2006, The Journal of clinical investigation.
[54] J. Qin,et al. Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways. , 2004, Molecular cell.
[55] C. Deng,et al. The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[56] R. Cardiff,et al. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[57] J. Torchia,et al. The Activity and Stability of the Transcriptional Coactivator p/CIP/SRC-3 Are Regulated by CARM1-Dependent Methylation , 2006, Molecular and Cellular Biology.
[58] A. Zhang,et al. Nuclear localization of coactivator RAC3 is mediated by a bipartite NLS and importin alpha3. , 2006, Biochemical and biophysical research communications.
[59] N. Heisterkamp,et al. Crkl Is Complexed with Tyrosine-phosphorylated Cbl in Ph-positive Leukemia (*) , 1995, The Journal of Biological Chemistry.
[60] R. V. van Etten,et al. c-Abl Has High Intrinsic Tyrosine Kinase Activity That Is Stimulated by Mutation of the Src Homology 3 Domain and by Autophosphorylation at Two Distinct Regulatory Tyrosines* , 2000, The Journal of Biological Chemistry.
[61] J. Auwerx,et al. Oncogenic steroid receptor coactivator-3 is a key regulator of the white adipogenic program , 2006, Proceedings of the National Academy of Sciences.
[62] Charis Eng,et al. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling , 1995, Nature.
[63] Michael B. Yaffe,et al. Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs , 2003, Nucleic Acids Res..